Equillium, Inc. EQ

About Equillium, Inc. (EQ): stock profile, AI score and financials

Equillium, Inc. (EQ) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores EQ at 21.8/100 on a composite quality score built from its SEC filings, placing it at rank #2,723 of 2,925 stocks — the bottom half of the AI-ranked universe. Areas of concern include balance sheet strength (3.5) and earnings quality (7.1), which score below median versus the broader universe. Shareholder dilution risk is elevated at 22.5/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Equillium, Inc. reports net income of $-4.7M, free cash flow of $-4.2M. Top institutional holders of EQ by reported 13-F value include Jupiter Topco, Decheng Capital, Affinity Asset Advisors, based on the most recent SEC filings. EQ trades on the Nasdaq exchange and files with the SEC under CIK 1746466. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate EQ daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Equillium, Inc. directly from SEC EDGAR.

Financials through the period ended Jun 30, 2026SEC EDGAR: CIK 1746466 →